Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 14:06
Evidence Synthesis
ELEMARB has accelerated its 53.01% in the last quarter, up from 16.05%.
The company's has also seen significant growth, accelerating from 9.48%. Additionally, ELEMARB's has increased, showing a decelerating daily trend. The indicate a decline in daily trading volume. Lastly, the company's has seen a slight increase, accelerating from 175.65 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.01 % | 16.05 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 16.05 % | 9.48 | ▲ |
| REVENUE_GROWTH_YOY | 30 % | -51.8 | ▲ |
| EPS_ACTUAL | 2.46 INR | — | - |
| EPS_SURPRISE_PERCENT | -0.513 % | — | - |
| PRICE_CHANGE_PERCENT | 1.907 % | — | - |
| DAILY_VOLUME | 76 shares | 478 | ▼ |
| CLOSE_PRICE | 179 INR | 175.65 | ▲ |